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1. Introduction
Graphene-based nanomaterials recently emerged 
as novel carriers in drug delivery applications [1, 2]. 
Graphene oxide (GO) and reduced GO (rGO) display 
advantageous characteristics as biosensing platforms 
due to the high surface area, excellent biocompatibility 
and ability to interact with proteins and polysaccharides 
[3–5]. GO exhibits wide fluorescence emission 
(280–500 nm) [6] that can be used to track the 
transport of the graphene-based nanocarriers to the 
particular cells by means of fluorescent microscopy 
R Dojčilović et al
045019
2D MATER.
© 2018 IOP Publishing Ltd
5
2D Mater.
2DM
2053-1583
10.1088/2053-1583/aad72b
4
1
12
2D Materials
IOP
13
August
2018
DUV fluorescence bioimaging study of the interaction of partially 
reduced graphene oxide and liver cancer cells
Radovan Dojčilović1,2, Jelena D Pajović3,4, Dušan K Božanić1,5 , Nataša Jović1, Vera P Pavlović6, 
Vladimir B Pavlović7,8, Lea Lenhardt Acković1, Ivana Zeković1, Miroslav Dramićanin1 , Slavka Kaščaková9,10, 
Matthieu Réfrégiers4, Goran Rašić11,12, Branislav Vlahović11,12,13 and Vladimir Djoković1,13
1 Vinča Institute of Nuclear Sciences, University of Belgrade, PO Box 522, 11001 Belgrade, Serbia
2 Department of Chemistry and Biochemistry, University of Notre Dame, 251 Nieuwland Science Hall, Notre Dame, IN 46556,  
United States of America
3 Faculty of Physics, University of Belgrade, PO Box 368, 11001 Belgrade, Serbia
4 DISCO beamline, Synchrotron SOLEIL, F-91192 Gif sur Yvette, France
5 DESIRS beamline, Synchrotron SOLEIL, F-91192 Gif sur Yvette, France
6 Faculty of Mechanical Engineering, University of Belgrade, 11000 Belgrade, Serbia
7 Faculty of Agriculture, University of Belgrade, 11000 Belgrade, Serbia
8 Institute of Technical Sciences, Serbian Academy of Sciences and Arts, Belgrade, Serbia
9 Inserm Unité 1193, F-94800 Villejuif, France
10 Univ. Paris-Sud XI, UMR-S1193, F-94800 Villejuif, France
11 North Carolina Central University, Durham, NC, United States of America
12 NASA University Research Center for Aerospace Device Research and Education and NSF Center of Research Excellence in Science and 
Technology Computational Center for Fundamental and Applied Science and Education, Durham, NC, United States of America
13 Authors to whom any correspondence should be addressed.
E-mail: vlahovic@nccu.edu and djokovic@vin.bg.ac.rs
Keywords: bioimaging, graphene oxide, fluorescence, cancer, cells
Supplementary material for this article is available online
Abstract
The interaction of partially reduced graphene oxide (prGO) and Huh7.5.1 liver cancer cells was 
investigated by means of DUV fluorescence bioimaging. The prGO sample was obtained by the 
reduction (to a certain extent) of the initially prepared graphene oxide (GO) nanosheets with 
hydrazine. The fluorescence of the GO nanosheets increases with time of the reduction due to a 
change in ratio of the sp2 and sp3 carbon sites and the prGO sample was extracted from the dispersion 
after 6 min, when the intensity of the fluorescence reached its maximum. The reduction process was 
left to proceed further to saturation until highly reduced graphene oxide (denoted here as rGO) was 
obtained. GO, prGO and rGO samples were investigated by structural (scanning electron microscopy 
(SEM), scanning transmission electron microscopy coupled with energy dispersive spectrometry 
(STEM-EDS)) and spectroscopic (UV–vis, photoluminescence (PL), Raman) methods. After that, 
Huh7.5.1 cells were incubated with GO, prGO and rGO nanosheets and used in bioimaging studies, 
which were performed on DISCO beamline of synchrotron SOLEIL. It was found that the prGO 
significantly enhanced the fluorescence of the cells and increased the intensity of the signal by ~2.5 
times. Time-lapse fluorescence microscopy experiments showed that fluorescence dynamics strongly 
depends on the type of nanosheets used. The obtained prGO nanostructure can be easily conjugated 
with aromatic ring containing drugs, which opens a possibility for its applications in fluorescence 
microscopy monitored drug delivery.
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[7]. In fluorescent bioimaging, it is also important to 
use hydrophilic probes with well-defined sizes and 
specific optical properties. It was shown that the optical 
properties of GO could be controlled by changing 
its surface chemistry [8–10]. GO is an electronically 
hybrid material that possesses both conducting π-states 
from sp2 carbon sites and a large energy gap between 
the σ-states of its sp3-bonded carbons. The control of 
the ratio of the sp2 and sp3 fractions by the reduction 
process enables one to tune its bandgap and, therefore, 
to controllably transform GO from an insulator to a 
graphene-like semi-conductor [11]. With the partial 
reduction of GO, it is possible to influence the size of 
sp2 clusters, which affects the fluorescence emission 
and enhances the quantum yield [8]. In the present 
study, we decided to investigate the interaction of this 
intermediate form, partially reduced graphene oxide 
(prGO), with cancer liver cells (Huh7.5.1 cell line) by 
using DUV fluorescence microscopy. We believe that 
the pronounced fluorescence of prGO will enable its 
easier detection in the certain cell compartments, 
which is very important if these nanostructures are 
going to be used in drug delivery applications.
The interaction of graphene-based nanosheets 
with live cells may induce significant changes in the 
functioning of the cells and distinct toxic effects. Previ-
ous optical microscopy studies revealed that GO and 
rGO are internalized in cells in a different way, while 
their toxicity is highly dependent on the presence 
of the surface oxygen groups [12, 13]. The changes 
in the metabolism may be followed by observing the 
changes in the autofluorescence of the cells, since 
autofluorescent species, particularly aromatic amino 
acids and NADH, are involved in mitochondrial 
function, energy metabolism, calcium homeostasis, 
gene expression, oxidative stress, aging and apoptosis 
[14, 15]. The study is focused on the fluorescence prop-
erties of the cancer Huh7.5.1 cells after their interac-
tion with GO, prGO and rGO sheets. We also followed 
the changes in fluorescence dynamics of these GO-
based species when they are in contact with the cells.
2. Materials and methods
2.1. GO and the reduced GO
GO was synthesized by using modified Hummers 
method according to the procedure found in [16]. 
A 150 g of expanded graphite (EG) was used as a 
starting material, while sulphuric acid (95%–98% 
H2SO4, Sigma Aldrich) was used as the intercalating 
compound. Sulphuric acid (6 ml) was added to 
the pilled pieces of EG and mixed at 0 °C for 2 h. 
The mixture was left overnight and kept at room 
temperature. Oxidation was carried out by adding 
450 mg of potassium permanganate (KMnO4). After 
adding 28 ml of DI water, the mixture was kept in oil 
bath at 90 °C–95 °C for 2 h. Then, the oxidized graphite 
mixture was cooled down to the room temperature. 
A possible reduction of the product was stopped by 
adding 84 ml of 3% solution of H2O2. Several cycles 
of centrifugation (at 5500 rpm) and washing with 5% 
HCl solution were conducted until brown solution of 
graphite oxide (GtO) was obtained. The sonication of 
GtO solution with Branson W-450 D Digital Soniﬁer 
with 20% amplitude (80 W) for 10 min resulted in a 
change of colour from light brown to light yellow. 
Transparent light yellow supernatants of GO were 
obtained after another cycle of centrifugation and 
washing.
The reduction of the obtained GO was carried out 
by using 30% solution of hydrazine hydrate (N2H4, 
Sigma Aldrich). First, the beaker with 0.1 mg ml−1 of 
GO solution was heated in oil bath at 95 °C. After that, 
100 µl of hydrazine solution was added into heated GO 
solution to initiate the reduction process. At certain 
time intervals during the reduction, equal amounts of 
GO were extracted and diluted with DI water in order 
to stop the process. The partially reduced GO samples 
extracted at different reduction times were stable for 
more than a month after the preparation. The reduced 
GO sample was obtained at the end of the preparation 
procedure (after 45 min of reduction). It was less sta-
ble; the sheets tended to agglomerate after few days. 
This sample was studied immediately after its prep-
aration.
2.2. Methods
The morphology of GO was investigated by using a 
JEOL JSM-6390 scanning electron microscope (SEM). 
Because of the low electrical conductivity of GO, 
the surface was covered with thin layer of gold. The 
micrographs of GO were obtained at operating voltage 
of 13 kV.
The structure and morphology of the GO, prGO 
and rGO samples were investigated by probe aberra-
tion corrected scanning transmission electron micro-
scope (STEM) (FEI Titan 80-300) coupled with a 
SuperX energy dispersive spectrometer (SuperX EDS) 
with the four silicon drift detectors (SDD) (Bruker). 
Aqueous dispersions of the GO, prGO and rGO were 
deposited on carbon coated copper grids using an 
automatic pipette. The samples were left to dry under 
ambient conditions before they were transferred to the 
microscope chamber.
A fully automated Raman microscope (LabRAM 
HR Evolution) was used for Raman spectroscopy 
measurements. The spectra were obtained over the 
Raman shift range from 1000 to 2000 cm−1 using 
acquisition time of 10 s. The samples were excited by 
532 nm laser light (with 1.08 mW of incident power) 
and the data were collected by using a 50  ×  objective.
The UV–vis absorption measurements of the 
aqueous dispersions were carried out on a Thermo 
Evolution 600 spectrophotometer.
The photoluminescence (PL) spectra of aqueous 
dispersions of GO, prGO and rGO were recorded using 
a PerkinElmer LS45 fluorescence spectrophotom-
eter. Fluorescence excitation emission matrices were 
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recorded on a Fluorolog-3 spectrofluorometer system 
(Model FL3-221, Horiba Jobin Yvon). Xenon lamp 
(450 W) was used as an excitation source. Both excita-
tion and emission monochromators were double grat-
ing, with dispersion of 2.1 nm mm−1 (1200 grooves 
nm−1). All measurements were performed in the front 
face geometry at room temperature. To obtain the flu-
orescence excitation emission matrices, the emission 
spectra were recorded in the range from 330 to 650 nm 
at 2 nm steps and in the excitations range from 270 to 
430 nm at 2.5 nm steps. For these measurements, exci-
tation slit was set at 6 nm, emission slit was at 2 nm and 
integration time was fixed to 0.4 ms. Variations of the 
excitation power were corrected using reference pho-
todetector.
2.3. Cell line and the preparation of biological 
samples
Human hepatocellular carcinoma-derived Huh7.5.1 
cells were routinely cultured as monolayer and were 
grown in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal calf serum, 
penicillin and streptomycin. The cells were maintained 
at 37 °C in a humidified atmosphere of 5% CO2.
For DUV fluorescence imaging studies, the 
Huh7.5.1 cells were plated in plastic Petri dishes con-
taining 25 mm round quartz coverslip and incubated 
for 24 h. Cell attachment was monitored by visible 
inspection using a microscope. Thereafter, cells were 
incubated with GO, prGO and rGO sheets for 5 h. The 
cell’s culture medium (3 ml) was mixed with 300 µl of 
the GO, prGO and rGO dispersions (30 µg ml−1). After 
the incubation, the cells were washed with PBS, fixed 
with 4% of PFA, rinsed in distilled water and air dried 
before being used for bioimaging. The control sample 
was prepared in the same way but without adding GO, 
prGO or rGO.
2.4. Deep-UV fluorescence microscopy
The fluorescence images of Huh7.5.1 cells and 
Huh7.5.1 cells incubated with GO, prGO and rGO 
were acquired on TELEMOS endstation of DISCO 
beamline (SOLEIL synchrotron facility, France). 
Synchrotron light source was monochromatized to 
provide an excitation wavelength of 270 nm and the 
flux of the beam was less than 7 · 1010 photons s−1. 
DISCO beamline is optimized for the investigations 
of the biological samples and the intensity of the beam 
was adjusted to minimize the possibility of damaging 
the cells. The fluorescence of the control and incubated 
cells was collected in the [327–353 nm], [370–410 
nm] and [420–480 nm] wavelength ranges for 30 s. 
To ensure consistency of the observations at least 30 
different locations (80  ×  80 µm) were investigated. 
An ultrafluar 100  ×  glycerin immersion objective 
(Zeiss, Germany) and PIXIS 1024-BUV EM-CCD 
camera (Princeton, USA) were used for recording 
images. Time-lapse experiments were performed to 
study the fluorescence dynamics of the control and 
incubated cells. The evolution of the fluorescence 
signal was followed by recording the fluorescent image 
every 2 min for 30 s. FIJI software [17] was employed in 
order to analyse the obtained fluorescence images. The 
normalization of original intensities I was performed 
by using following formula:
f (ti) =
I(ti)− Imin
Imax − Imin , (1)
where f(ti) are the normalized intensities with respect 
to the minimum (Imin) and maximum (Imax) values of 
the {I(ti)} set.
3. Results and discussion
3.1. Structure and optical properties of GO, prGO 
and rGO
Modified Hummers method was used for the 
fabrication of GO and figure 1 shows the SEM 
micrograph of the obtained GO sample. The SEM 
image of a selected exfoliated thin sheet of GO is shown 
in figure 1(b).
As stated in the introduction, the partial reduc-
tion of GO can be used to modify the optical prop-
erties of the sheets. It was shown that the reduction 
process is highly sensitive to the amount of reducing 
agent (hydrazine) [18–20]. A careful tuning of the 
concentration of hydrazine and the reduction con-
ditions enabled the extraction of the intermediates 
with particular properties. The fluorescence measure-
ments of the intermediate products of the reduction 
(supporting information figure S1 (stacks.iop.org/
TDM/5/045019/mmedia)) showed that the GO sam-
Figure 1. (a) Scanning electron microscopy (SEM) micrograph of the obtained GO sheets. (b) Selected GO sheet at higher 
magnification.
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ple partially reduced for 6 min exhibited the highest 
fluorescence intensity. For this reason, the structural 
and optical measurements were focused on this par-
ticular sample (it will be referred in the text as prGO 
unless designated otherwise). Figure 2 shows high-
resolution TEM micrographs of the initial GO, prGO 
and rGO samples.
The elemental mappings of the highlighted sur-
face areas are shown under the corresponding TEM 
images. The oxygen maps (red) reveal that the oxygen 
content decreases with the time of reduction (figure 2). 
Thus the C/O ratio is increasing with reduction time, 
which is also confirmed by EDS results (figure 3). Fab-
rication of GO led to stable 2 d nanostructures with 
C/O ~ 4. After the reduction, C/O ratio increased to ~7 
for prGO and ~10 for rGO.
The changes in carbon–oxygen ratios were also fol-
lowed by Raman spectroscopy. Figure 4 shows Raman 
spectra of the GO, prGO and rGO samples with typi-
cal D and G peaks at 1345 cm−1 and 1588 cm−1 shifts, 
respectively. The G band originates from the in-plane 
vibrations of sp2 carbon atoms and represents doubly 
degenerate phonon mode (E2g symmetry) at the center 
of the Brillouin zone. On the other hand, the D peak 
(A1g symmetry mode) comes from the presence of the 
sp3 carbons and from the defect-induced breathing 
mode of sp2 rings [21, 22]. Consequently, the reduc-
tion process can be followed by observing the changes 
Figure 2. HRTEM micrographs and elemental maps of carbon and oxygen for (a) GO, (b) GO partially reduced for 6 min (prGO) 
and (c) reduced graphene oxide (rGO). The elemental composition is determined for the selected areas on the sheets surfaces  
(green outlines).
Figure 3. Energy dispersive spectroscopy (EDS) spectra of (a) GO (b) prGO and (c) rGO samples. The ratios of carbon and oxygen 
atoms increase with increasing in reduction time.
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in the relative intensity of these two bands (ID/IG). 
The ID/IG ratio of GO is 0.96 and increases after the 
reduction to 1.12 and 1.60 for prGO and rGO, respec-
tively (figure 4). The reduction affects the in-plane 
vibrations of sp2 carbon atoms, which is reflected 
in changes in the intensity of the G mode (figure 4) 
23, 24]. Stankovich et al [25] attributed an increase in 
ID/IG ratio to a decrease in the average size of the sp2 
domains upon reduction i.e. to the formation of new 
graphitic domains that are smaller in size (~2 nm) 
than those initially present in GO but, at the same time, 
more numerous in number. The results presented in 
figure 4 are also in agreement with the Raman spec-
tra reported in the other rGO studies where hydrazine 
hydrate was used as a reduction agent [26, 27].
The attenuation of light by GO aqueous disper-
sions during the reduction process was monitored by 
UV visible spectroscopy (figure 5). The absorption 
spectra of GO dispersion exhibits two peaks at 220 nm 
and 310 nm which belong to specified transitions of 
π–π* (C  =  C) and n  −  π* (C=O), respectively. There 
is a red shift of the absorbance peak at 220 nm dur-
ing the reduction. It can also be seen that the shoulder 
at 310 nm disappeared after the reduction, which is 
attributed to the decrease in concentration of carboxyl 
groups [8]. The color of the dispersions also changes 
during the reduction. The photo of the dispersions is 
given in the inset of figure 5.
Due to the functionalization (oxidation)-induced 
opening of the energy gap, GO is expected to exhibit 
PL. For the excitation in the UV part of the EM spec-
trum, GO shows pronounced fluorescence emission 
between 400 and 500 nm, which originates from radia-
tive recombination of electron-hole pairs located in 
small sp2 domains [8]. The intensity of the PL emis-
sion strongly depends on the time of reduction of GO. 
It increases with reduction time, reaches the maximum 
after 6 min and then starts to decrease. The fluorescence 
Figure 4. Raman spectra of GO, prGO (GO partially reduced for 6 min) and rGO normalized according to equation (1). The 
rectangles indicate D and G bands and the ratios of their original intensities are given in the inset.
Figure 5. Normalized UV–vis spectra of GO, prGO (partially reduced for 2 and 6 min) and rGO. The inset shows the photo of the 
obtained GO, prGO (partially reduced for 6 min) and rGO dispersions.
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intensity does not change significantly after pro-
longed reduction (>10 min). As mentioned above, 
we will focus on the emission properties of the sample 
obtained after 6 min of reduction (prGO). PL spectra of 
the initial GO sample and GO samples reduced at dif-
ferent times are included in Supporting information 
(figure S1).
The emission excitation matrices of the GO, prGO 
and rGO are shown in figure 6. As can be seen, there 
are two distinct regions with pronounced PL inten-
sity noted as region I (λexc  =270 nm, Δλem  =380–
550 nm) and region II (λexc  =  300 nm, Δλem  =  350–
450 nm). Since we intended to study the interaction of 
GO-based nanosheets with cancer liver cells by DUV 
Figure 6. Emission excitation matrices obtained for (a) GO, (b) prGO and (c) rGO samples. The 270–430 nm excitation and 
330–650 nm emission wavelength ranges were used.
Figure 7. (a) PL emission spectra of GO, prGO and rGO obtained at λexc  =  270 nm. (b) The same PL spectra normalized with 
respect to the maximum of the emission intensity. The rectangles indicate the emission ranges F1 [327–353 nm], F2 [370–410 nm] 
and F3 [420–480 nm] used in deep UV fluorescence imaging.
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imaging, we were interested in the first region with 
excitation at 270 nm.
Single emission spectra extracted from the emis-
sion excitation matrices for λexc  =  270 nm are shown 
in figure 7(a).
It can be seen that the prGO yields the highest fluo-
rescence. Apparently, the partial reduction induced 
specific rearrangement of the honeycomb network 
which resulted in more effective recombination of 
excited electrons that further led to the increase in flu-
orescence intensity. In figure 7(b), we present the nor-
malized PL spectra from figure 7(a). The grey rectan-
gles indicate the emission ranges that are used for the 
collection of the fluorescence signal in DUV imaging: 
F1 [327–353 nm], F2 [370–410 nm] and F3 [420–480 
nm]. Obviously, the maximum of emission is in F3 
range, while all three GO-based species show negligi-
ble emission in F1 range.
3.2. DUV Fluorescence imaging of Huh7.5.1 cells 
incubated with GO, prGO and rGO
Selected visible microscopy images of the control 
Huh7.5.1 cells and the cells incubated with GO, prGO 
and rGO are shown in figure 8.
A careful analysis of the cells from various loca-
tions along the samples suggested that the morph ology 
of the cells was slightly affected by the presence of GO. 
GO incubated cancer cells closely resemble the form of 
the control cells and folded GO aggregates rarely pen-
etrate into the interior of the cells (figure 8, the 1st and 
2nd columns). In the case of the cells incubated with 
prGO and rGO, they are more affected by the pres-
ence of the nanosheets and there are nume-rous sites 
where the sheets are internalized in the cells. It is obvi-
ous that degree of the internalization strongly depends 
on the presence of surface ligands and, consequently, 
on the reduction level. The agglomerates of internal-
ized reduced graphene oxides are indicated by red 
arrows (figure 8 the 3rd and 4th columns). This is in 
agreement with literature data, which showed that cells 
had the ability to internalize, actively fold and com-
partmentalize relatively large pieces of the sheets and 
remain viable [12, 13, 28–30].
Deep UV imaging of treated and untreated 
Huh7.5.1 cancer liver cells was performed by using the 
excitation wavelength of 270 nm and the fluorescence 
emission was monitored in three spectral windows F1 
[327–353 nm], F2 [370–410 nm] and F3 [420–480 nm]. 
Figure 8. Bright field micrographs of control Huh 7.1.5 cells (1st column) and Huh 7.1.5 cells incubated with GO, prGO and rGO 
(2nd, 3rd and 4th columns, respectively). Red arrows indicate localization of GO, prGO and rGO at cell sites. Blue arrows indicate 
non-internalized entities.
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GO, prGO and rGO fluorescence centers have a wide 
blue emission that primarily falls into the F3 range (fig-
ure 7(b)), and partially into the F2 range. The Huh7.5.1 
cells have intrinsic fluorescence that has been detected 
in all three spectral emission ranges, with comparable 
fluorescence intensities. Bright field and corresponding 
fluorescent images of the control and incubated cells in 
F3 emission range are shown in figure 9. In the second 
row of figure 9, we show LUT fluorescent images of the 
cells, while in the fourth row are the same images nor-
malized with respect to the highest intensity observed 
for the prGO incubated sample for comparison pur-
poses. As can be seen, the fluorescence of GO-incubated 
is similar to the fluorescence of the control cells (figure 
9, the 2nd and 4th row). Also, the fluorescence emission 
in both samples is mainly homogeneously distributed 
in the cytoplasmic region. On the other hand, the fluo-
rescence intensities of the prGO/Huh and rGO/Huh 
samples are much higher than the autofluorescence of 
the control sample.
Furthermore, it seems that the maxima of the fluo-
rescence coincide with the cell compartments con-
taining internalized prGO and rGO species. In order 
to show this more clearly, we introduced bright field 
images with marked positions of the fluorescence 
maxima (green dots) in the third row of figure 9. To 
establish the positions of the maxima, the signal inten-
sities were scaled to include the fluorescence that 
exceeds  >85% of the maximum intensity (the details 
about the scaling procedure and maxima selections 
can be found in supporting information, figure S2). It 
is well known that the nucleoli are the brightest intra-
Figure 9. Bright field microscopy (the 1st row) and corresponding DUV fluorescent images (the 2nd row) of the control and GO, 
prGO and rGO incubated Huh7.5.1 cells in F3 [420–480 nm] emission range. In the 3rd row, the green dots indicate the positions 
of the local fluorescence maxima (the positions where the intensity of the fluorescence signal exceeds 85% of the maximum 
fluorescence intensity). The 4th row shows fluorescence images of control and GO, prGO and rGO incubated cells normalized with 
respect to the maximum intensity obtained for prGO incubated cells.
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cellular autofluorescent sites [14, 31] in the nuclei and 
this is indeed true for the control and GO + Huh sam-
ples (the nucleoli are indicated by yellow arrows). In 
the case of prGO + Huh and rGO  + Huh samples, the 
maxima are positioned on the black entities (indicated 
by red arrows) suggesting that the fluorescence comes 
from internalized prGO and rGO. We have selected 
typical DUV fluorescent images of the control as well 
as GO, prGO and rGO incubated cells, but the similar 
fluorescent behavior was noticed at different locations 
along the sample (the additional images were included 
in supporting information, figure S3). It is important 
to notice that the prGO and rGO aggregates local-
ized in the vicinity of the cells do not fluoresce. The 
lower fluorescence intensity of the prGO (or rGO) 
aggregates located outside the cell is a consequence of 
the agglomeration of the sheets. The agglomeration 
results in the formation of π-stacked complexes, which 
in turn induces a static quenching [32]. This effect is 
less pronounced in the case of internalized prGO/rGO 
because the intracellular material may separate the 
sheets and prevent the π–π stacking. Further, we calcu-
lated the average fluorescent intensities per single cell 
(number of cells n  >  30) for all 4 samples, which are 
presented in figure 10. The results show that the cells 
with internalized prGO nanostructures have 2.5 times 
higher fluorescence intensity in F3 range than that of 
the control samples. It can also be seen that the aver-
age fluorescence intensities in all three spectral ranges 
decrease slightly after incubation with GO. It is possi-
ble that GO quenches the main cell fluorophores such 
as tryptophan, tyrosine, phenylalanine and NADH 
[33, 34]. Nevertheless, the observed changes are within 
the experimental error (figure 10). An increase in the 
fluorescence intensity of Huh7.5.1 cells incubated 
with rGO, relative to those treated with GO, could be 
attributed to better internalization of rGO by the cells 
and consequently reduced π–π stacking. These obser-
vations are confirmed by additional DUV fluorescent 
microscopy measurements on another set of samples. 
Obviously, the presence of the reduced GO nanostruc-
tures affects the overall fluorescence of the Huh7.5.1 
cells. We further investigated the fluorescence dynam-
ics with consecutive imaging of the treated and 
untreated cells.
Selected local fluorescent maxima are followed in 
the time-lapse experiment (see figure S4 in supporting 
information for details). The time dependence of the 
average intensity of local maxima (normalized accord-
ing to equation (1)) in F1, F2 and F3 emission ranges 
are shown in figure 11. The original average intensities 
at particular time intervals and the standard deviations 
are given in Supporting information (table S1).
It can be seen that the presence of GO based species 
does not influence the fluorescence kinetics signifi-
cantly in F1 range. The incubated and control cells show 
similar time-dependence of the fluorescence intensity 
(figure 11(a)). The fluorescent intensity decreases with 
prolonged time, with the slowest decay noticed in the 
case of the prGO + Huh cells. The time dependence of 
the fluorescence intensity does not change significantly 
when the detection was switched from F1 to F2 win-
dow (figure 11(b)). The intensity decreases with time 
in this range as well. However, the degrees of changes 
are more pronounced. Also, the fastest intensity decay 
was observed for the GO incubated cells and it should 
be attributed to the GO-induced emission quenching 
of tryptophan-containing species mentioned above 
[33]. In the F3 range (figure 11(c)), the dependence of 
the fluorescence intensity from time is somewhat dif-
ferent. As can be seen in figure 11(c), the normalized 
fluorescence intensity of the control cells increases 
with time. Their fluorescence mostly originates from 
the presence of NADH, which exhibits maximum flu-
orescence in this range [15]. Also, the time dependence 
of the fluorescence intensity of the pure NADH mat-
erial [35] is similar to that of the control cells observed 
in figure 11(c).
Figure 10. The average fluorescent intensity per single cell for untreated Huh7.5.1 cells (control), as well as GO, prGO and rGO, 
incubated Huh7.5.1 cells (number of cells counted n  >  30). The error bars represent standard deviations of the fluorescence 
intensity.
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It should also be noticed that the fluorescence of 
the cells incubated with GO increases almost linearly 
with time, while the increase itself is slower than that 
observed for the untreated cells. On the other hand, 
the reduced graphene oxides (prGO and rGO) affect 
the fluorescence dynamics differently. The time-lapse 
experiments show that the fluorescence intensities of 
prGO and rGO incubated cells reach maxima after 
approximately 6 min and then start to decrease (fig-
ure 11(c)). The obtained results apparently show that 
GO, prGO and rGO nanosheets affect the fluorescence 
dynamics in a different way. GO obviously interacts 
with the cells’ autofluorophores, tryptophan (main 
fluorescence in the F2 range) and NADH (main fluo-
rescence in the F3 range), and induces partial quench-
ing through non-radiative processes. The time-lapse 
measurements in the F3 range showed the presence 
of two general processes in the fluorescence of prGO 
and rGO incubated Huh7.5.1 cells in contrast to the 
continuous increasing of the fluorescence of the con-
trol cells. In figure 11(d), we tried to follow the time 
dependence of the fluorescence intensities of the auto-
fluorophore (NADH) and fluorophore prGO in the 
prGO incubated cells separately. The details of the pro-
cedure are explained in the supporting information 
(figure S5). Briefly, the positions of the fluorescence 
maxima in F1 range (which correspond almost exclu-
sively to the fluorescence of the autofluorophores) 
were fixed. After that, the time evolution of these fluo-
rescence centers was followed in the F3 range together 
with the time evolution of strongest fluorescence cent-
ers in the same range (which coincide with the posi-
tions of prGO sheets). As the results in figure 11(d) 
show, the fluorescence dynamics of the autofluoro-
phores in the F3 range closely resembles the dynam-
ics of control cells in the same range. The fluorescence 
intensity is increasing with time until it reaches satur-
ation. This suggests that the change in fluorescence 
dynamics of prGO + Huh cells with respect to that of 
the control cells is indeed the consequence of the pres-
ence of prGO fluorophores. A deeper understanding 
of the effects of prGO on the time evolution of fluo-
rescent signal would require a separate study. Never-
theless, the presented results (figures 9 and 10) clearly 
show that the average fluorescence intensity of the cells 
significantly increases if they are incubated with prGO 
sample. Since it contains both sp2 and sp3 domains, 
it may interact with aromatic ring containing drugs 
through π–π stacking but also with polar molecules via 
epoxide, hydroxyl, and carboxylic groups. This is why 
Figure 11. The dependences of the average intensities of local maxima (normalized according to equation (1)) from time in (a) 
F1 [327–353 nm] (b) F2 [370–410 nm] and (c) F3 [420–480 nm] emission ranges. (d) The evolution of the fluorescent signal that 
comes from the autofluorophores (fluorescent maxima previously fixed by observing the fluorescence in the F1 range) and from 
prGO fluorophores in the F3 range (the details about the procedure of finding maxima are explained in the supporting information, 
figure S5). The curve that corresponds to control Huh cells in (c) is also included in (d) for comparison.
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we believe that prGO can also be used in drug deliv-
ery applications. The successful delivery of the drug 
conjugated to prGO nanosheets might be monitored 
by fluorescence imaging and we plan to continue our 
research in this direction.
4. Conclusion
In this article, DUV fluorescence spectroscopy was used to 
study the interaction of prGO with the cancer liver cells. A 
modified Hummers method was used for the fabrication 
of GO and the reduction was performed in the presence 
of hydrazine hydrate. The partial reduction of GO was 
achieved by controlling the duration of the reduction 
process. It was found that the sample partially reduced 
for 6 min showed the highest fluorescence intensity and 
it was further used in bioimaging tests. GO, prGO and 
rGO samples were studied using various microscopy 
and spectroscopic methods in order to establish their 
structure and physical properties. STEM micrographs 
of GO, prGO and rGO showed the presence of isolated 
monolayers. Elemental analysis revealed that the C/O 
ratio values were dependent on the time of reduction, 
which was also confirmed by Raman spectroscopy. 
The change in the optical properties was monitored 
by PL and UV–vis spectroscopies. The prGO showed 
the highest intensity of PL emission for the excitation 
that belongs to the DUV part of the EM spectrum. The 
fluorescent GO, prGO and rGO nanostructures were 
used in the DUV fluorescence imaging study of the 
cancer liver cell line Huh7.5.1. The interaction of the 
prGO nanostructures with the cells resulted in a strong 
increase in the fluorescence intensity in F3 [420–480 
nm] range with respect to the autofluorescence of the 
control sample. Time-lapse studies showed that the 
time dependence of the fluorescence emission from GO, 
prGO and rGO internalized cells is different from that 
of the intrinsic fluorescence of the untreated cells. The 
prGO nanostructure was suggested as a possible carrier 
for cancer drugs since its pronounced fluorescence 
might be used for monitoring the delivery process. In the 
forthcoming study, we will focus on the drug conjugated-
prGO nanostructures and their interaction with cancer 
cells.
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